NEW YORK (Reuters) - Johnson & Johnson must pay $8 billion (6.6 billion pounds) in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.
Of the five units it owns, New Delhi wants to close two and sell another two
About a third of all generic drugs consumed in the US are made in India, invoking greater scrutiny of plants in the country